• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking & Ass

  2026-04-17

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) bridges real-time mRNA tracking with robust protein expression, leveraging both Cy5 fluorescence and bioluminescence readouts. Explore optimized workflows, evidence-backed protocol parameters, and actionable troubleshooting tips for advanced translational research.

• ATM-Targeted TACE Silencing: Alleviating Obesity-Induced Dia

  2026-04-16

  This study introduces a non-viral oligopeptide system (ATS-9R) for targeted gene silencing in visceral adipose tissue macrophages, focusing on TACE knockdown to reduce inflammation and improve insulin sensitivity in obesity-induced type 2 diabetes. The findings establish a mechanistically precise strategy for metabolic disease intervention via Prohibitin-mediated endocytosis.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Lab G

  2026-04-15

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction and analysis by inhibiting multiple classes of cellular proteases. It is intended for workflows that require preservation of divalent cations, such as phosphorylation studies and enzyme assays, and should not be used where EDTA is essential or DMSO is incompatible.

• Cyclic Pifithrin-α Hydrobromide: Precision p53 Inhibition in

  2026-04-14

  Cyclic Pifithrin-α hydrobromide is a validated p53 inhibitor widely used to dissect p53-mediated apoptosis and DNA damage responses. Its selectivity allows differentiation between p53-dependent and -independent cellular processes, streamlining cancer and neuroinflammation studies. This article reviews its mechanism, benchmarks, and workflow integration for research use.

• MDL 28170: Calpain Inhibitor Strategies for Neuroprotection

  2026-04-13

  MDL 28170 stands out as a selective, cell-permeable calpain inhibitor, enabling robust neuroprotection and assay specificity across neurological, cardiac, and infectious disease models. This article translates the latest mechanistic and workflow insights into actionable protocols, troubleshooting tips, and advanced applications for translational research.

• HyperScript RT SuperMix for qPCR: Accelerating Reliable cDNA

  2026-04-13

  HyperScript RT SuperMix for qPCR transforms two-step qRT-PCR, enabling reproducible gene expression analysis from low-concentration or structurally complex RNA. Its advanced enzyme and primer blend unlock high-fidelity cDNA synthesis, supporting breakthrough workflows in cancer biomarker discovery and challenging tissue assays.

• Adefovir in HBV Research: Applied Workflows and Assay Advanc

  2026-04-12

  Adefovir (GS-0393) stands out as a high-confidence probe and antiviral in hepatitis B virus research, combining potent DNA polymerase inhibition with selective OAT1 transport phenotyping. This guide translates the latest pharmacokinetic breakthroughs into robust lab protocols, troubleshooting strategies, and workflow optimizations for reproducible results.

• DAPI (hydrochloride): Precision DNA Staining in Research Wor

  2026-04-12

  DAPI (hydrochloride) delivers unparalleled specificity and reliability as a DNA visualization tool across histochemistry, cytometry, and advanced cancer research. Its robust minor groove binding and versatility in both fixed and live cells empower precise cell cycle and chromatin analyses, as showcased in recent epithelial ovarian cancer studies.

• ML385: Applied NRF2 Inhibitor Workflows in Cancer & Ferropto

  2026-04-11

  ML385 enables targeted NRF2 signaling pathway inhibition across cancer and oxidative stress research, uniquely supporting both in vitro and in vivo protocol optimization. New evidence from neurodegeneration models reveals how ML385 clarifies the mechanistic role of NRF2, offering actionable troubleshooting strategies and cross-domain insights.

• Minoxidil Sulphate in Vascular & Hair Growth Research Workfl

  2026-04-11

  Minoxidil sulphate, the active metabolite of minoxidil, is a high-purity compound enabling reproducible studies in vascular biology and hair follicle research. This guide details optimized protocols, comparative advantages, and troubleshooting strategies to maximize experimental success using APExBIO’s Minoxidil sulphate.

• Adefovir (SKU C6629): Scenario-Driven Solutions for Relia...

  2026-04-10

  This in-depth article addresses core pain points in HBV research and transporter studies, demonstrating how Adefovir (SKU C6629) from APExBIO delivers reproducible, sensitive, and robust results. Drawing on real-world laboratory scenarios, it provides practical, data-backed guidance for cell viability, proliferation, and cytotoxicity assays. The discussion highlights Adefovir’s validated pharmacology and actionable workflow advantages, referencing authoritative protocols and peer-reviewed literature.

• Canagliflozin: Potent SGLT2 Inhibitor for Diabetes Research

  2026-04-09

  Canagliflozin enables precise modulation of glucose metabolism in animal models, advancing both mechanistic and translational research in diabetes, nephropathy, and metabolic disease. Its low-nanomolar potency and robust in vivo efficacy distinguish it as a benchmark SGLT2 inhibitor for dissecting glucose homeostasis and kidney protection pathways.

• Sitagliptin Phosphate Monohydrate: Potent DPP-4 Inhibitor...

  2026-04-08

  Sitagliptin phosphate monohydrate is a potent, selective DPP-4 inhibitor widely used in type II diabetes treatment research. It enables precise modulation of incretin hormones, offering a robust benchmark for metabolic enzyme inhibitor workflows.

• Redefining Translational Cardiovascular and Sepsis Resear...

  2026-04-08

  Explore how 5-(N,N-dimethyl)-Amiloride (hydrochloride) is catalyzing a new paradigm in translational research through selective Na+/H+ exchanger inhibition. This thought-leadership article fuses mechanistic insight, rigorous validation, and actionable guidance for investigators unraveling the complexities of intracellular pH regulation, ischemia-reperfusion injury, and endothelial dysfunction—while referencing the latest biomarker discoveries in sepsis and highlighting APExBIO’s role in research innovation.

• Talabostat Mesylate: Advancing FAP and DPP4 Inhibition in...

  2026-04-07

  Discover how Talabostat mesylate, a specific DPP4 and fibroblast activation protein inhibitor, is reshaping cancer biology and hematopoiesis studies. This in-depth article explores its molecular mechanisms, translational applications, and emerging roles in immune modulation beyond current research paradigms.

15738 records 1/1050 page Next 12345 下5页 Last page